RI
HRTX icon

RTW Investments’s Heron Therapeutics HRTX Stock Holding History

RTW Investments’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-386,787
Closed -$6.66M – 36
2016
Q3 		$6.66M Buy
+386,787
New +$7.18M 2.01% 13

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

RTW Investments's HRTX Position: Q4 2016 in Review

RTW Investments sold out of Heron Therapeutics (HRTX) in Q4 2016, closing a stake of 386,787 shares — an estimated $6.66M sold.

RTW Investments first reported a position in HRTX in Q3 2016 and held it in 1 quarter. The position peaked at $6.66M in Q3 2016. 99 funds tracked by Wall St. Rank hold HRTX as of Q4 2016.

  • RTW Investments reported no remaining Heron Therapeutics position as of Q4 2016 after selling out during the quarter.
  • RTW Investments sold 386,787 Heron Therapeutics shares in Q4 2016, an estimated $6.66M.
  • RTW Investments first reported a position in Heron Therapeutics in Q3 2016 and held it in 1 quarter.
  • RTW Investments's Heron Therapeutics position peaked at $6.66M in Q3 2016.
  • 99 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2016.

Based on RTW Investments's 13F filing for Q4 2016, filed 15 Feb 2017.